Manjistha (Rubia cordifolia) is a perennial climbing herb native to India, Nepal, and parts of Southeast Asia and Africa, whose roots have been used in Ayurvedic medicine for millennia. It holds a central place in classical Ayurveda as a premier 'rakta shodhaka' — a blood-purifying herb — and has been prescribed historically for skin diseases, bleeding disorders, and inflammatory conditions. Modern research is beginning to validate many of these traditional uses, identifying a rich array of anthraquinone compounds as its primary active constituents.

Manjistha works primarily through its anthraquinone compounds (like alizarin and purpurin), which have demonstrated anti-inflammatory, antioxidant, and immune-modulating effects in research. It appears to support lymphatic flow and help the body clear metabolic waste and toxins more efficiently, which in Ayurvedic terms is described as clearing 'ama' from the blood. It also shows meaningful antibacterial activity against acne-causing bacteria and inhibits certain inflammatory pathways that drive chronic skin and joint conditions.

Powder (churna) mixed with warm water or milk is the traditional Ayurvedic form and remains popular. Capsules and tablets standardized to anthraquinone content offer more precise dosing. Liquid extracts provide faster absorption. Topical pastes made from Manjistha powder are applied directly for skin conditions like acne and hyperpigmentation. Decoctions (simmered tea) are used when a gentle, sustained effect is preferred.

• Acne and skin breakouts
• Eczema and psoriasis
• Skin hyperpigmentation and dark spots
• Lymphatic congestion and swelling
• Chronic inflammation and joint pain
• Urinary tract infections (UTIs)
• Menstrual irregularities and heavy periods
• Wound healing and skin repair
• Autoimmune-related skin flares

• Recurrence of acne breakouts with consistent long-term use
• Progression of oxidative stress-related skin aging

Manjistha is a root herb extract and is not found as a component of common foods. However, certain dietary choices support the same blood-purifying, lymphatic, and anti-inflammatory pathways that Manjistha targets. Prioritize: (1) Bitter greens like dandelion, arugula, and radicchio, which support liver and lymphatic detox pathways; (2) Beets, which promote blood flow and liver function; (3) Turmeric and ginger, which reduce systemic inflammation through overlapping pathways; (4) Cruciferous vegetables (broccoli, kale, Brussels sprouts), which support phase II liver detoxification; (5) Berries rich in antioxidants (blueberries, amla/Indian gooseberry), which reduce oxidative stress on the skin. Minimize processed foods, refined sugars, and alcohol, which increase inflammatory burden and counteract Manjistha's effects.

• Orange or red discoloration of urine and stool (harmless, due to anthraquinone pigments)
• Mild stomach upset or nausea — especially on an empty stomach or at high doses
• Loose stools or mild laxative effect with excessive doses
• Potential skin sensitivity in rare cases when used topically in high concentrations
• Not recommended during pregnancy due to traditional classification as a uterine stimulant
• Avoid in severe kidney disease — anthraquinone compounds are renally cleared

• Recommended daily: Powder (churna): 3–6 grams per day in divided doses. Capsules/tablets standardized to anthraquinone content: typically 500 mg–1,000 mg, 2–3 times daily. Liquid extract: 2–4 mL of 1:2 extract, 2–3 times daily. Follow product-specific guidance as standardization varies.
• Best time of day: Morning and evening doses are traditional; splitting the dose helps maintain steady levels throughout the day.
• With or without food: Best taken with food to minimize any stomach upset. Traditionally mixed with warm water, honey, or warm milk.
• Time to effect: Skin improvements: 4–8 weeks. Deeper systemic and inflammatory benefits: 8–12 weeks of consistent use.
• How long to take it: Ayurvedic tradition typically recommends use in cycles: 8–12 weeks on, followed by a 4-week break before resuming. For chronic conditions, longer supervised use is common. Avoid indefinite unsupervised high-dose use due to theoretical concerns about very prolonged anthraquinone exposure.